These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 33650635)
1. Elucidating the role of GRIM-19 as a substrate and allosteric activator of pro-apoptotic serine protease HtrA2. Kummari R; Dutta S; Patil S; Mudrale SP; Bose K Biochem J; 2021 Mar; 478(6):1241-1259. PubMed ID: 33650635 [TBL] [Abstract][Full Text] [Related]
2. Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease. Aspholm EE; Lidman J; Burmann BM Nat Commun; 2024 May; 15(1):4592. PubMed ID: 38816423 [TBL] [Abstract][Full Text] [Related]
3. Structural modeling and role of HAX-1 as a positive allosteric modulator of human serine protease HtrA2. Chaganti LK; Dutta S; Kuppili RR; Mandal M; Bose K Biochem J; 2019 Oct; 476(20):2965-2980. PubMed ID: 31548268 [TBL] [Abstract][Full Text] [Related]
4. GRIM-19 associates with the serine protease HtrA2 for promoting cell death. Ma X; Kalakonda S; Srinivasula SM; Reddy SP; Platanias LC; Kalvakolanu DV Oncogene; 2007 Jul; 26(33):4842-9. PubMed ID: 17297443 [TBL] [Abstract][Full Text] [Related]
8. Role of conserved regulatory loop residues in allosteric propagation of serine protease HtrA2. Parui AL; Singh N; Dutta S; Bose K Biochem Biophys Res Commun; 2022 Feb; 594():63-68. PubMed ID: 35074587 [TBL] [Abstract][Full Text] [Related]
9. Dissecting the role of interprotomer cooperativity in the activation of oligomeric high-temperature requirement A2 protein. Toyama Y; Harkness RW; Kay LE Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34446566 [TBL] [Abstract][Full Text] [Related]
11. Oligomeric assembly regulating mitochondrial HtrA2 function as examined by methyl-TROSY NMR. Toyama Y; Harkness RW; Lee TYT; Maynes JT; Kay LE Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33692127 [TBL] [Abstract][Full Text] [Related]
13. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. Martins LM; Turk BE; Cowling V; Borg A; Jarrell ET; Cantley LC; Downward J J Biol Chem; 2003 Dec; 278(49):49417-27. PubMed ID: 14512424 [TBL] [Abstract][Full Text] [Related]
14. Structural exploration with AlphaFold2-generated STAT3α structure reveals selective elements in STAT3α-GRIM-19 interactions involved in negative regulation. Mishra S; Kumar S; Choudhuri KSR; Longkumer I; Koyyada P; Kharsyiemiong ET Sci Rep; 2021 Nov; 11(1):23145. PubMed ID: 34848745 [TBL] [Abstract][Full Text] [Related]
15. Structural basis of protein substrate processing by human mitochondrial high-temperature requirement A2 protease. Toyama Y; Harkness RW; Kay LE Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2203172119. PubMed ID: 35452308 [TBL] [Abstract][Full Text] [Related]
16. cFLIP - An interacting partner and a novel substrate for pro-apoptotic serine protease HtrA2. Natu K; Dutta S; Bose K Biochem Biophys Rep; 2024 Jul; 38():101682. PubMed ID: 38511187 [TBL] [Abstract][Full Text] [Related]
17. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. Verhagen AM; Silke J; Ekert PG; Pakusch M; Kaufmann H; Connolly LM; Day CL; Tikoo A; Burke R; Wrobel C; Moritz RL; Simpson RJ; Vaux DL J Biol Chem; 2002 Jan; 277(1):445-54. PubMed ID: 11604410 [TBL] [Abstract][Full Text] [Related]
18. Loss of GSK-3β mediated phosphorylation in HtrA2 contributes to uncontrolled cell death with Parkinsonian phenotype. Bose K; Wagh A; Mishra V; Dutta S; Parui AL; Puja R; Mudrale SP; Kulkarni SS; Gai PB; Sarin R Int J Biol Macromol; 2021 Jun; 180():97-111. PubMed ID: 33716130 [TBL] [Abstract][Full Text] [Related]
19. Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain. Zhang Y; Appleton BA; Wu P; Wiesmann C; Sidhu SS Protein Sci; 2007 Aug; 16(8):1738-50. PubMed ID: 17656586 [TBL] [Abstract][Full Text] [Related]
20. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity. Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]